Covid-19

Latest News On The Coronavirus Outbreak

Au Revoir, Public Health Emergency

The Biden administration this week announced it would let the covid-19 public health emergency lapse on May 11, even as the Republican-led House was voting to immediately eliminate the special authorities of the so-called PHE. Meanwhile, anti-abortion forces are pressuring legislators to both tighten abortion restrictions and pay for every birth in the nation. Margot Sanger-Katz of The New York Times, Rachel Roubein of The Washington Post, and Victoria Knight of Axios join KHN’s chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness about the rollout of the national 988 suicide prevention hotline.

KHN’s ‘What the Health?’: The Covid Response Coordinator Speaks

In this special episode of KHN’s “What the Health?” Dr. Ashish Jha, the White House coronavirus response coordinator, talks with host Julie Rovner, KHN’s chief Washington correspondent, about where we are in the pandemic and how we should transition out of the public health emergency. This episode was taped on Dec. 20.

KHN’s ‘What the Health?’: Health Spending? Only Congress Knows

Top negotiators in Congress have agreed to a framework for government spending into next year, but there are details to iron out before a vote — such as the scheduled Medicare payment cuts that have providers worried. Also, the Biden administration reopens its program allowing Americans to request free covid-19 home tests, as hopes for pandemic preparedness measures from Congress dim. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Rebecca Adams of KHN join KHN’s Mary Agnes Carey to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.

KHN’s ‘What the Health?’: Medicaid Machinations

The lame-duck Congress has returned to Washington with a long health care to-do list and only a little time. Meanwhile, some of the states that have not yet expanded Medicaid eligibility under the Affordable Care Act are rethinking those decisions. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Fred Clasen-Kelly, who reported and wrote the latest KHN-NPR “Bill of the Month” feature, about a mysterious mishap during minor surgery.